Skip to content
DataLookout
Menu

NCT06027086

DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

StatusActive, Not Recruiting
PhasePhase 1/2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 9 versions: 8 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 41 words Show 4 more changesShow less
    • Enrollment closed, study ongoing
    • Final enrollment: 6 participants (planned 27)
    • Secondary endpoints: details revised at 2 of 2 entries
    • Site details revised
  2. Minor Site contact updatedv7
  3. Minor Primary completion date: Aug 1, 2028 to Sep 1, 2028
    • Study completion date: Aug 1, 2029 to Sep 1, 2033
    v6
  4. Notable Primary completion date: Feb 1, 2027 to Aug 1, 2028
    • Study completion date: Feb 1, 2027 to Aug 1, 2029
    • Start date: Feb 6, 2024 to Feb 12, 2024
    v5
  5. Notable Eligibility criteria expanded, about 33 wordsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 1, 2024 to Feb 6, 2024
    • Site details revised
    v3
  2. Notable Start date: Jan 1, 2024 to Feb 1, 2024
    • Primary and study completion dates: Jan 1, 2027 to Feb 1, 2027
    v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Number of participants experiencing drug-related adverse events (AEs) requiring treatment discontinuation
Timeframe: 4 years
Objective response rate (ORR) using immune Response Evaluation Criteria for Solid Tumors (RECIST 1.1)
Timeframe: 4 years

Secondary (2)

Progression-free Survival (PFS)
Overall survival (OS)

Arms and interventions

Durvalumab and DRP-104Experimental

Drugs: Durvalumab, DRP-104

Sites

1 site in 1 country

  • Johns Hopkins SKCCCBaltimore, Maryland, United States